At Rally Foundation, we believe that one discovery can change everything and sometimes, all it needs is a seed.  From 2007 to 2015, we served as philanthropic seed investors in the work of Dr. Jackie Kraveka, D.O., at the Medical University of South Carolina. With early, critical funding from Rally, Dr. Kraveka led groundbreaking preclinical studies focused on a tough childhood cancer: neuroblastoma.  Neuroblastoma is a cancer that starts in immature nerve cells, most often in the adrenal...

Jennifer Kalish, M.D., Ph.D., and her team at Children’s Hospital of Philadelphia are studying a rare condition called Beckwith-Wiedemann syndrome (BWS). Kids with BWS are at a higher risk of developing liver cancer. With a three-year Rally Career Development Award, Dr. Kalish is uncovering how BWS liver cells become cancerous and how to stop them.  What Dr. Kalish’s Team Has Discovered  Super-Active Liver Cells: The team found that liver cells in kids with BWS use much more energy than normal...

Jason Yustein, M.D., Ph.D., has spent years studying osteosarcoma, the most common bone cancer in kids and teens. Osteosarcoma is tough because it spreads fast and often comes back after treatment. For kids who relapse, time matters.  Thanks to early and continued funding from Rally Foundation for Childhood Cancer Research, first at Baylor College of Medicine and now at Emory University, Dr. Yustein and his team found new possible ways to stop osteosarcoma. One of the most exciting results is...